Similar Search Results

Trips & Pharmaceutical Patent Protection in Pakistan : Opportunities and Policy Challenges --- Evidences from India & Brazil

Fatima, Tafseer - 2014

interest in perspective of public health. The thesis examines an underlying research question: Using the experience of India … to answer the research question as identified for the study. Brazil and India were in a similar position prior to …, India & certain other developing countries related to the pharmaceutical patent protection & key issues relevant to the …

Persistent link: https://www.econbiz.de/10014142808

Patent analysis for medicines and biotherapeutics in trials to treat COVID-19

Ravi, Srividya - 2020

Persistent link: https://www.econbiz.de/10012433647

Introducing patent protection in the pharmaceutical sector : a first evaluation of the Mexican case

Zuniga, Maria Pluvia; Combe, Emmanuel - In: Région et développement (2002) 16, pp. 191-221

Persistent link: https://www.econbiz.de/10001761509

Patents for Covid-19 vaccines are based on public research: a case study on the privatization of knowledge

Florio, Massimo - 2021 - This version October 11, 2021

Persistent link: https://www.econbiz.de/10012642904

Patents, public agency, and prices : the case of Covid-19 vaccines

Sturn, Richard - 2020

Persistent link: https://www.econbiz.de/10012488073

National and global vaccine procurement in a pandemic situation: rational patent replacement option

Welfens, Paul J. J. - 2021

Persistent link: https://www.econbiz.de/10012495913

Innovation and patenting activities of COVID-19 vaccines in WTO members : analytical review of Medicines Patent Pool (MPP) COVID-19 Vaccines Patent Landscape (VaxPaL)

Chiang, Ting-Wei; Wu, Xiaoping - 2022 - Manuscript date: 18 January 2022

This working paper provides a statistical analysis of 74 patent families which cover subject matter relevant to ten COVID-19 vaccines. These vaccines have accounted for 99% of the global COVID-19 vaccine production as of 31 December 2021, comprising over ten billion doses. Eight of them, namely...

Persistent link: https://www.econbiz.de/10012818093

Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? : new evidence from patenting data

Rathi, Sawan; Majumdar, Adrija; Chatterjee, Chirantan - In: Technological forecasting and social change : an … 198 (2024), pp. 1-15

Persistent link: https://www.econbiz.de/10015075658

Covid-19 vaccines, innovation, and intellectual property rights

Cozzi, Guido; Galli, Silvia - 2022

Should the intellectual property rights on the first Covid-19 vaccines be temporarily lifted in applying the Trade-Related Aspect of Intellectual Property (TRIPS) flexibility? Is it right to grant the first generation of Covid-19 vaccines a special treatment from an IPR perspective? On what...

Persistent link: https://www.econbiz.de/10013254230

Patent analysis for medicines and biotherapeutics in trials to treat COVID-19

Ravi, Srividya - 2022

This report provides an analysis of patents covering medicines in trials to treat COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the examination of the claims contained in...

Persistent link: https://www.econbiz.de/10013194325